Dynamic Technology Lab Private LTD Gritstone Bio, Inc. Transaction History

Dynamic Technology Lab Private LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$1.28 - $2.85 $14,812 - $32,980	11,572 New	11,572 $24,000
Q2 2022 Aug 12, 2022	SELL	$1.77 - $4.34 $88,184 - $216,227	-49,822 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$4.03 - $12.19 $200,782 - $607,330	49,822 New	49,822 $205,000
Q2 2021 Aug 13, 2021	SELL	$8.13 - $10.2 $206,119 - $258,600	-25,353 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$4.07 - $27.11 $103,186 - $687,319	25,353 New	25,353 $239,000
Q4 2020 Feb 11, 2021	SELL	$2.57 - $4.22 $38,670 - $63,498	-15,047 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$2.63 - $8.09 $252 - $776	-96 Reduced 0.63%	15,047 $40,000
Q2 2020 Aug 14, 2020	BUY	$5.69 - $8.17 $86,163 - $123,718	15,143 New	15,143 $101,000

35.4M

395K

132K

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.